Valproic Acid in Pregnancy Revisited: Neurobehavioral, Biochemical and Molecular Changes Affecting the Embryo and Fetus in Humans and in Animals: A Narrative Review

Keyphrases

• Fetus 100%
• Valproic Acid 100%
• Narrative Review 100%
• Biochemical Changes 100%
• Neurobehavioral Development 100%
• Molecular Changes 100%
• Epilepsy 28%
• Congenital Malformations 28%
• Teratogenic Effects 28%
• Teratogenic 28%
• Daily Dose 14%
• Teratogenic Potential 14%
• During Pregnancy 14%
• Clinical Trials 14%
• Attention Deficit Hyperactivity Disorder 14%
• Neurodevelopmental Problems 14%
• High Dose 14%
• Human Placenta 14%
• Folic Acid 14%
• Neural Tube Defects 14%
• Anticonvulsant 14%
• High Concentration 14%
• Malformation 14%
• Human Data 14%
• Metabolism 14%
• Folate 14%
• Antiepileptic Drugs 14%
• Cognitive Ability 14%
• Language Impairment 14%
• Breast Cancer 14%
• DNA Methylation (DNAm) 14%
• Malformation Rate 14%
• Mood Stabilizers 14%
• Hypospadias 14%
• Autism 14%
• S-adenosylmethionine 14%
• Nursing 14%
• Milk 14%
• Histone 14%
• Fetal Blood 14%
• Cardiac Anomalies 14%
• Neurodevelopmental Syndrome 14%
• Epigenetic Modulators 14%
• Antiseizure Medication 14%
• Orofacial Clefts 14%
• Skeletal Malformations 14%
• Urogenital Malformation 14%
• Prostatic Cancer 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Sodium Valproate 100%
• Congenital Malformation 57%
• Anticonvulsive Agent 28%
• Folic Acid 28%
• Teratogenesis 28%
• Heart Disease 14%
• Side Effect 14%
• Clinical Trial 14%
• Attention Deficit Disorder 14%
• Prevalence 14%
• Skeleton Malformation 14%
• Neural Tube Defect 14%
• Syndrome 14%
• Hypospadias 14%
• Breast Cancer 14%
• Histone 14%
• Prostate Cancer 14%
• Heart Atrium Septum Defect 14%
• Mood Stabilizer 14%
• Urogenital Tract Malformation 14%
• Language Disability 14%